CANCER TARGETED GENE PANEL LUNG Test
Test Name: CANCER TARGETED GENE PANEL LUNG Test
Components:
- ALK1
- ROS1
- MET amplification
- MET mutation
- KRAS
- BRAF
- ERBB2
- EGFR
Price: 4680.0 AED
Sample Condition: Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Duly filled NGS Test Requisition Form is mandatory.
Report Delivery: Sample Tue by 9 am; Report 10 Working days
Method: FISH, NGS
Test type: Cancer
Doctor: Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.
Test Details:
The Cancer Targeted Gene Panel: Lung Test is a genetic test that analyzes a specific set of genes associated with lung cancer. It is designed to identify specific mutations or alterations in these genes that may contribute to the development or progression of lung cancer. This test can help in the diagnosis, prognosis, and treatment planning for individuals with lung cancer by providing information about the genetic characteristics of the tumor. The results of this test can help guide personalized treatment decisions, such as the selection of targeted therapies or clinical trials that may be more effective for the patient’s specific genetic profile.
Test Name | CANCER TARGETED GENE PANEL LUNG Test |
---|---|
Components | *ALK1 *ROS1 *MET amplification *MET mutation*KRAS *BRAF*ERBB2*EGFR |
Price | 4680.0 AED |
Sample Condition | Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Duly filled NGS Test Requisition Formis mandatory. |
Report Delivery | Sample Tue by 9 am; Report 10 Working days |
Method | FISH, NGS |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
Test Details |
The Cancer Targeted Gene Panel: Lung Test is a genetic test that analyzes a specific set of genes associated with lung cancer. It is designed to identify specific mutations or alterations in these genes that may contribute to the development or progression of lung cancer. This test can help in the diagnosis, prognosis, and treatment planning for individuals with lung cancer by providing information about the genetic characteristics of the tumor. The results of this test can help guide personalized treatment decisions, such as the selection of targeted therapies or clinical trials that may be more effective for the patient’s specific genetic profile. |